It’s been just over one year since the JOBS Act was passed, which makes equity- and debt-based crowdfunding legal for accredited and nonaccredited investors. Although the U.S. Securities and Exchange Commission has yet to finalize and implement specific rules around those provisions, several online platforms have plowed ahead and created private portals for accredited investors […]
The medical device sector is ravenous for fresh capital. But they’re not desperate enough to trust crowdfunding. That was confirmed at this week’s 10x Medical Device Conference in Minneapolis, Minnesota, during a panel on new sources for capital. It was a bone-jarringly frank conversation that featured two entrepreneurs including Steve Anderson, CEO of Preceptis Medical. […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Pricewaterhouse Coopers and the National Venture Capital Association released trends from their quarterly MoneyTree Report on venture capital investing on Friday, and while the findings aren’t surprising, they don’t spell much good news for life science companies. Both biotech and medical device companies saw a marked decrease in the number of deals and dollars compared […]
After two decades of clinical practice, a couple of healthcare startups and a handful of angel investing networks, Jose Bolanos noticed a few things about the process of medical innovation. First, venture capitalists were struggling in healthcare and were moving toward later-stage investments. Secondly, physicians were self-funding a lot of their projects. And third, many […]
While venture capitalists are usually focused on investing in innovation, this healthcare VC is turning the tables and doing some creative thinking of its own. Last week, life sciences venture firm Domain Associates unveiled an interesting partnership with Beijing-based Elite Consulting, a consulting and financial advisory firm for the Chinese pharmaceutical and medical device industry. […]
A little more than a year ago the American Heart Association launched an accelerator to fund biotechnolgy and medical device startups to fill a crucial gap in research funding caused by the increasing hesitance of investors to risk support on early-stage innovation. Now, it’s getting ready for a $2 million fundraising round to invest in […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Life science venture capital activity may have picked up in the last quarter of 2012, but it still wasn’t enough to overwhelm the dismal showing in the first half of the year. A new Pricewaterhouse Coopers Money Tree Report found that the number of life science start-ups that received venture capital for the first time […]
Early stage medical device and biotech venture capitalist Mike Carusi with Advanced Technology Ventures (ATV) had a busy conference schedule at the J.P. Morgan Healthcare Conference in San Francisco earlier in January. What was different this year was the number of meetings the big “strategics” — the large medical device and pharmaceutical players — were willing to […]
Now that it’s Dec. 21 and the world hasn’t ended, let’s talk about 2013. Venture capital investors have expressed confidence in the coming year for healthcare IT markets, while listing biotech among the sectors they’re least confident about. While investors are running a tight ship, “good companies are still being funded,” said Bill Trainor of […]
Venture capital investment in medical devices pretty much fell off the cliff in the third quarter. The PricewaterhouseCoopers MoneyTree Report found that medical device companies received a combined $434 million from 65 deals in the third quarter, which marks a 37 percent drop in dollar amount and a 27 percent decline in the number of deals […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
A survey of 31 San Francisco venture capitalists’s outlook for the next six to 18 months has found confidence up slightly in the third quarter of the year, but not for life science and healthcare investing where the landscape will get more challenging before it improves. The Silicon Valley Venture Capitalist Confidence Index measured 3.53 […]
A group of investors suggested reverse mergers, licensing strategies and oncology companies during a panel on how to fund a startup company in biotech or medtech. One investor said four forces were combining to make 2013 a great year for medtech.
The third and last presidential debate had few healthcare moments, but one issue that was raised did have some relevance, particularly for any healthcare and life science companies that have benefited from government funding. Should government back companies or should government stick to research grants? The clearest example of healthcare companies that have benefited from […]
Before Medtronic acquired Ardian in 2010, it led a $47 million series C round for the company. Boston Scientific led an $11 million round for Intelect Medical two years before buying it for $78 million. According to some investors, these kinds of strategic investments are the way of the future in biotech and medical devices. […]
Here’s another name to add to the list of life science-focused venture firms raising or closing funds over $100 million this year: Longitude Venture Partners. The VC firm that specializes in medical device, biotechnology, diagnostics and R&D tools investment revealed in a U.S. Securities and Exchange Commission filing last week that it has raised more […]